| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Mesa Nilda is a Director at UNITED THERAPEUTICS Corp. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $2.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 9, 2025 | UTHR United Therapeutics Corp | Director | Sell | 187 | $481.63 | $90,064.83 | -3.4% | +11.2% | - | |
| Jun 24, 2025 | UTHR United Therapeutics Corp | Director | Sell | 645 | $289.99 | $187,045.23 | -11.7% | +43.0% | - | |
| Dec 30, 2024 | UTHR United Therapeutics Corp | Director | Sell | 255 | $355.77 | $90,720.10 | -4.4% | -13.8% | +38.7% | |
| Nov 8, 2024 | UTHR United Therapeutics Corp | Director | Sell | 224 | $412.28 | $92,350.27 | -3.7% | -13.7% | +9.5% | |
| Jun 25, 2024 | UTHR United Therapeutics Corp | Director | Sell | 266 | $318.58 | $84,741.85 | -5.0% | +11.5% | -10.4% | |
| Mar 27, 2024 | UTHR United Therapeutics Corp | Director | Sell | 325 | $237.80 | $77,285.00 | -5.7% | +31.1% | +26.6% | |
| Dec 19, 2023 | UTHR United Therapeutics Corp | Director | Sell | 605 | $244.90 | $148,164.50 | -9.6% | -2.6% | +48.8% | |
| Sep 13, 2023 | UTHR United Therapeutics Corp | Director | Sell | 383 | $222.36 | $85,164.22 | -5.7% | +13.2% | +53.4% | |
| May 5, 2023 | UTHR United Therapeutics Corp | Director | Sell | 374 | $214.81 | $80,337.07 | -6.1% | +8.3% | +22.5% | |
| Nov 7, 2022 | UTHR United Therapeutics Corp | Director | Sell | 290 | $268.57 | $77,885.71 | -4.5% | -4.3% | -13.6% |